Daniel Bradshaw

10PUBLICATIONS
28CO-AUTHORS
Disease surveillanceImmunogenetics (incl. genetic immunology)Medical virologyCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 09, 2026
A systematic review of Human T-cell Lymphotropic Virus type-1 (HTLV-1) seroprevalence worldwide and an update on HTLV-1 diagnoses and associated diseases in England and Wales.

|Sep 26, 2025
Real-world Prevalence of Nonintegrase INSTI Resistance-Associated Mutations and Virological Outcomes in People Who Have Recently Acquired HIV-1 in the United Kingdom.

Christine Kelly, James S Lester, Daniel Bradshaw

|Jul 14, 2023
Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease.

Daniel Bradshaw, Iga Abramowicz, Stephen Bremner

|Apr 27, 2023
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial.

Maxime Desmarets, Simone Hoffmann, Charline Vauchy

|Sep 16, 2021
COVID-19 mortality among people with diagnosed HIV compared to those without during the first wave of the COVID-19 pandemic in England.

Alison E Brown, Sara E Croxford, Sophie Nash

|May 18, 2021
Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy.

David A Smith, Daniel Bradshaw, Jean L Mbisa

Pageof 2

Frequent Collaborators

2 joint publications

Alison E Brown

2 joint publications

Caroline Sabin

1 joint publications

Marianne Martinello

1 joint publications

Emma C Thomson